Overview

A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia

Status:
Completed
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient with Alzheimer's Disease or Vascular Dementia
Phase:
Phase 2
Details
Lead Sponsor:
Charsire Biotechnology Corp.